1-15 of 21
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Patient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
CME/CEPatient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Eden Miller, DO, D-ACD, D-ABOM
A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
CME/CEA New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Optimizing Body Composition Changes in the Era of Incretin-Based Weight Loss Therapies
CME/CEOptimizing Body Composition Changes in the Era of Incretin-Based Weight Loss Therapies
Augusto Enrique Caballero-Robles, MD
Carla Prado, PhD, RD, FCAHS
Lars Johansson, PhD
Donna H. Ryan, MD
Stefan D. Anker, MD, PhD
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
CME/CEFrom Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
Jorge Plutzky, MD
Bradley Eilerman, MD, MHI
AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
CME/CEAACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
Susan L Samson, MD, PhD, FRCPC, FACE
Lawrence Blonde, MD, FACP, FACE
- advertisement
Cushing's at the Core: Leading-Edge Strategies for Diagnosis and Medical Management of Cushing Syndrome
CME/CECushing's at the Core: Leading-Edge Strategies for Diagnosis and Medical Management of Cushing Syndrome
Honey East, MD
Amir H. Hamrahian, MD
Rosario Pivonello, MD, PhD
The Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
CME/CEThe Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
Hanford Yau, MD, CCD, FACP, FACE
Eden Miller, DO, D-ACD, D-ABOM
Diabetes Educators EmpowerED: Strategies for Optimizing Patient Outcomes With Emerging Weekly Insulin Therapies
CME/CEDiabetes Educators EmpowerED: Strategies for Optimizing Patient Outcomes With Emerging Weekly Insulin Therapies
Mara Fiorio, DCN, RD, LD, BC-ADM, CDCES
Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES, FADCES, FCCP
Richard E. Pratley, MD
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Francisco Javier Ampudia-Blasco, MD, PhD
Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
CME/CEContinuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
Christian Mende, MD, FACP, FACN, FASN, FASH, FAHA
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
- advertisement
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
Shifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidence-Based Therapies to Optimize Patient Outcomes
CME/CEShifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidence-Based Therapies to Optimize Patient Outcomes
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Stephen J. Greene, MD
Anne Louise Peters, MD
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
